Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
FDA Approves Yervoy to Reduce the Risk of Melanoma Returning After Surgery
Read More
FDA Approves New Treatment for Advanced Pancreatic Cancer
Read More
FDA Approves Nucala to Treat Severe Asthma
Read More
FDA Approves Cotellic as Part of Combination Treatment for Advanced Melanoma
Read More
FDA Approves New Treatment for HIV
Read More
FDA Approves New Pill to Treat Certain Patients with Non—Small-Cell Lung Cancer
Read More
FDA Approves Darzalex for Patients with Previously Treated Multiple Myeloma
Read More
FDA Approves Modified Antihemophilic Factor for Hemophilia A
Read More
FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma
Read More
FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma
Read More
1
2
3
4
5
Page 2 of 26
Results 11 - 20 of 253